(Q39673276)

13 September 2017

1 reference

title

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance (English)

1 reference

13 September 2017

0 references

1 reference

de Groot R

1

1 reference

13 September 2017

Smith AL

series ordinal

2

1 reference

13 September 2017

language of work or name

1 reference

1 October 1987

1 reference

Clinical Pharmacokinetics

13 September 2017

1 reference

13 September 2017

13

1 reference

13 September 2017

4

1 reference

13 September 2017

228-253

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198713040-00002

13 September 2017

0 references

cites work

Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)

1 reference

12 December 2020

Clinical pharmacology of amikacin and kanamycin

1 reference

12 December 2020

The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers.

1 reference

12 December 2020

Ceftazidime disposition in acute and stable cystic fibrosis

1 reference

12 December 2020

Aminoglycoside clearance in patients with cystic fibrosis

1 reference

12 December 2020

Overview of acylureidopenicillin pharmacokinetics.

1 reference

12 December 2020

Quantitative aspects of lung pathology in cystic fibrosis

1 reference

12 December 2020

Dose-Dependent Pharmacokinetics of Azlocillin Compared to Mezlocillin

1 reference

12 December 2020

Penetration of piperacillin into bronchial mucosa and sputum

1 reference

12 December 2020

Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies

1 reference

12 December 2020

Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics

1 reference

12 December 2020

Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis

1 reference

12 December 2020

Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa

1 reference

12 December 2020

The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species

1 reference

12 December 2020

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis

1 reference

12 December 2020

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

12 December 2020

Antibiotic use in cystic fibrosis.

1 reference

12 December 2020

Pharmacokinetics of ticarcillin in man.

1 reference

12 December 2020

Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods

1 reference

12 December 2020

Cefsulodin kinetics in healthy subjects after intramuscular and intravenous injection.

1 reference

12 December 2020

Two-compartment comparison of gentamicin and tobramycin in normal volunteers

1 reference

12 December 2020

Cephalosporin therapeutics in cystic fibrosis

1 reference

12 December 2020

The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds

1 reference

12 December 2020

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

1 reference

12 December 2020

Clinical pharmacology of timentin (ticarcillin and clavulanic acid)

1 reference

12 December 2020

Influence of age on tobramycin pharmacokinetics in patients with normal renal function

1 reference

12 December 2020

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics of azlocillin in children with cystic fibrosis

1 reference

12 December 2020

Cimetidine use in children with cystic fibrosis: inhibition of hepatic drug metabolism

1 reference

12 December 2020

Clinical Pharmacokinetics of Aminoglycoside Antibiotics

1 reference

12 December 2020

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

1 reference

12 December 2020

Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response

1 reference

12 December 2020

Dose ranging study and constant infusion evaluation of ciprofloxacin

1 reference

12 December 2020

Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis

1 reference

12 December 2020

Biliary concentrations of piperacillin in patients undergoing cholecystectomy

1 reference

12 December 2020

Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.

1 reference

12 December 2020

Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis

1 reference

12 December 2020

Cloxacillin absorption and disposition in cystic fibrosis

1 reference

12 December 2020

Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin

1 reference

12 December 2020

BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa

1 reference

12 December 2020

Piperacillin: human pharmacokinetics after intravenous and intramuscular administration

1 reference

12 December 2020

Renal clearance of gentamicin in cystic fibrosis

1 reference

12 December 2020

Comparative In Vivo Activities of Cefsulodin, Sulbenicillin, and Gentamicin Against Pseudomonas aeruginosa

1 reference

12 December 2020

Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function

1 reference

12 December 2020

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

1 reference

12 December 2020

State of the art: chronic cor pulmonale

1 reference

12 December 2020

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

1 reference

12 December 2020

Pharmacokinetics of piperacillin following intravenous administration

1 reference

12 December 2020

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

1 reference

12 December 2020

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

12 December 2020

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

1 reference

12 December 2020

Individualization of tobramycin dosage in patients with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics of azlocillin in healthy subjects.

1 reference

12 December 2020

Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis

1 reference

12 December 2020

Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum

1 reference

12 December 2020

Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis.

1 reference

12 December 2020

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

1 reference

12 December 2020

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

1 reference

12 December 2020

Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.

1 reference

12 December 2020

Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs

1 reference

12 December 2020

Pharmacokinetics of netilmicin in children with and without cystic fibrosis

1 reference

12 December 2020

Pharmacokinetic concepts ? Drug binding, apparent volume of distribution and clearance

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

12 December 2020

Administration o gentamicin to obese patients

1 reference

12 December 2020

Dose Dependence of Piperacillin Pharmacokinetics

1 reference

12 December 2020

Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin

1 reference

12 December 2020

Piperacillin pharmacokinetics in pediatric patients

1 reference

12 December 2020

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults

1 reference

12 December 2020

Azlocillin pharmacokinetics in patients with cystic fibrosis

1 reference

12 December 2020

Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)

1 reference

12 December 2020

Difference in trimethoprim pharmacokinetics between children and adults

1 reference

12 December 2020

Netilmicin and gentamicin multidose kinetics in normal subjects

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

1 reference

12 December 2020

Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with Gentamicin

1 reference

12 December 2020

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

1 reference

12 December 2020

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

1 reference

12 December 2020

Resistance to trimethoprim in 1978-79 compared with 1973-75.

1 reference

12 December 2020

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

12 December 2020

Multicompartment pharmacokinetics of netilmicin

1 reference

12 December 2020

Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis

1 reference

12 December 2020

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

12 December 2020

Ticarcillin vs carbenicillin: Clinical pharmacokinetics

1 reference

12 December 2020

Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis

1 reference

12 December 2020

Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis

1 reference

12 December 2020

Malabsorption of Bile Acids in Children with Cystic Fibrosis

1 reference

12 December 2020

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum

1 reference

12 December 2020

The pharmacokinetics of amikacin in children

1 reference

12 December 2020

Comparison of radioimmunoassay and enzyme immunoassay methods in determining gentamicin pharmacokinetic parameters and dosages

1 reference

12 December 2020

Effect of glucocorticoids and ACTH on antipyrine clearance in children

1 reference

12 December 2020

Blood volume changes in patients with cystic fibrosis

1 reference

12 December 2020

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

1 reference

12 December 2020

Quantitative Inhibition of Haemophilus influenzae by Trimethoprim/Sulfamethoxazole

1 reference

12 December 2020

Gentamicin disposition in children with chronic renal failure.

1 reference

12 December 2020

Pharmacokinetics of Trimethoprim and Sulfamethoxazole in Normal Subjects and in Patients with Renal Failure

1 reference

12 December 2020

Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers

1 reference

12 December 2020

Pharmacokinetics of tobramycin in cystic fibrosis

1 reference

12 December 2020

Comparison of the Activities of the New Ureidopenicillins Piperacillin, Mezlocillin, Azlocillin, and Bay k 4999 Against Gram-Negative Organisms

1 reference

12 December 2020

Pharmacokinetics of intravenously administered piperacillin in preadolescent children

1 reference

12 December 2020

Tobramycin: an overview

1 reference

12 December 2020

Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.

1 reference

12 December 2020

Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function

1 reference

12 December 2020

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects

1 reference

12 December 2020

In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.

1 reference

12 December 2020

Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.

1 reference

12 December 2020

Multiple-dose amikacin kinetics in pediatric oncology patients

1 reference

12 December 2020

Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis

1 reference

12 December 2020

Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis

1 reference

12 December 2020

Correlation of netilmicin agar dilution and disk diffusion susceptibilities

1 reference

12 December 2020

Pharmacokinetics of Methicillin in Patients with Cystic Fibrosis

1 reference

12 December 2020

The effect of fever on antipyrine metabolism in children

1 reference

12 December 2020

10.2165/00003088-198713040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

13 September 2017

0 references

1 reference